| 2024-04-02 | Sale | Voyager Therapeutics, Inc. VYGR | President and CEO | 12,115 0.0222% | $9.86 | $119,454 | -14.93% | |
| 2024-02-21 | Sale | Voyager Therapeutics, Inc. VYGR | President and CEO | 13,033 0.0278% | $7.46 | $97,226 | +12.17% | |
| 2023-04-03 | Sale | Voyager Therapeutics, Inc. VYGR | President and CEO | 7,437 0.0187% | $7.83 | $58,232 | +2.19% | |
| 2021-06-07 | Sale | Biogen Inc. BIIB | Head of Research & Development | 7,672 0.0057% | $440.00 | $3.38M | -39.39% | |
| 2020-11-04 | Sale | Biogen Inc. BIIB | EVP, Research & Development | 3,000 0.0018% | $350.00 | $1.05M | -22.4% | |
| 2018-02-27 | Sale | Biogen Inc. BIIB | EVP, Chief Medical Officer | 518 0.0002% | $290.83 | $150,650 | +10.13% | |
| 2018-02-23 | Sale | Biogen Inc. BIIB | EVP, Chief Medical Officer | 1,816 0.0009% | $293.44 | $532,887 | +9.06% | |
| 2018-02-20 | Sale | Biogen Inc. BIIB | EVP, Chief Medical Officer | 1,486 0.0007% | $292.00 | $433,912 | +10.94% | |
| 2018-02-15 | Sale | Biogen Inc. BIIB | EVP, Chief Medical Officer | 2,588 0.0012% | $298.85 | $773,424 | +5.94% | |
| 2017-04-03 | Sale | Biogen Inc. BIIB | EVP CMO Neuro & Neurodegenerat | 3,962 0.0019% | $274.08 | $1.09M | +6.38% | |
| 2017-03-01 | Sale | Biogen Inc. BIIB | EVP CMO Neuro & Neurodegenerat | 1,946 0.0009% | $290.07 | $564,476 | -0.13% | |
| 2016-02-25 | Sale | Biogen Inc. BIIB | EVP CMO Neuro & Neurodegenerat | 366 0.0002% | $261.90 | $95,855 | +8.33% | |
| 2016-02-17 | Sale | Biogen Inc. BIIB | EVP CMO Neuro & Neurodegenerat | 1,444 0.0006% | $256.16 | $369,895 | +6.55% | |
| 2016-02-09 | Sale | Biogen Inc. BIIB | EVP CMO Neuro & Neurodegenerat | 1,704 0.0008% | $246.54 | $420,104 | +13.03% | |
| 2015-12-04 | Sale | Biogen Inc. BIIB | EVP CMO Neuro & Neurodegenerat | 882 0.0004% | $277.00 | $244,314 | -1.36% | |
| 2015-03-27 | Sale | Biogen Inc. BIIB | Grp SVP, Chief Medical Officer | 860 0.0004% | $430.12 | $369,903 | -30.42% | |
| 2015-03-02 | Sale | Biogen Inc. BIIB | Grp SVP, Chief Medical Officer | 6,348 0.0027% | $409.49 | $2.6M | -25.68% | |
| 2015-02-17 | Sale | Biogen Inc. BIIB | Grp SVP, Chief Medical Officer | 836 0.0003% | $389.11 | $325,296 | -20.9% | |
| 2015-02-10 | Sale | Biogen Inc. BIIB | Grp SVP, Chief Medical Officer | 2,286 0.001% | $398.16 | $910,192 | -20.04% | |
| 2015-02-09 | Sale | Biogen Inc. BIIB | Grp SVP, Chief Medical Officer | 1,712 0.0007% | $398.05 | $681,462 | -20.34% |